Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (357)

71

TAFRO syndrome successfully treated with tocilizumab : A case report and systematic review

enthalten in: Modern rheumatology | 2018

von Sakai, K. | Maeda, T. | Kuriyama, A. | +3

72

Safety and Efficacy of PD-1/PD-L1 Inhibitors in Treatment-Naive and Chemotherapy-Refractory Patients With Non-Small-Cell Lung Cancer : A Systematic Review and Meta-Analysis

enthalten in: Clinical lung cancer | 2018

von Khunger, M. | Jain, P. | Rakshit, S. | +5

73

Dupilumab treatment in moderate-to-severe atopic dermatitis : A systematic review and meta-analysis

enthalten in: Journal of dermatological science | 2018

von Wang, F. | Tang, X. | Wei, C. | +3

74

Risk of fatigue in cancer patients receiving anti-EGFR monoclonal antibodies : results from a systematic review and meta-analysis of randomized controlled trial

enthalten in: International journal of clinical oncology | 2018

von Zhu, J. | Zhao, W. | Liang, D. | +4

75

Systematic Review and Meta-Analysis : Preoperative Vedolizumab Treatment and Postoperative Complications in Patients with Inflammatory Bowel Disease

enthalten in: Journal of Crohn's & colitis | 2018

von Law, C. | Narula, A. | Lightner, A. | +3

76

Tocilizumab and refractory Takayasu disease : Four case reports and systematic review

enthalten in: Autoimmunity reviews | 2018

von Decker, P. | Olivier, P. | Risse, J. | +2

77

Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs : systematic review and meta-analysis

enthalten in: BMJ (Clinical research ed.) | 2018

von Baxi, S. | Yang, A. | Gennarelli, R. | +4

78

Comparative effectiveness of abatacept, apremilast, secukinumab and ustekinumab treatment of psoriatic arthritis : a systematic review and network meta-analysis

enthalten in: Rheumatology international | 2018

von Kawalec, P. | Holko, P. | Moćko, P. | +1

79

Lipid Management in Chronic Kidney Disease : Systematic Review of PCSK9 Targeting

enthalten in: Drugs | 2018

von Zheng-Lin, B. | Ortiz, A.

80

Surrogate end points for overall survival in trials of PD-(L)1 inhibitors for urinary cancers : a systematic review

enthalten in: Immunotherapy | 2018

von Abdel-Rahman, O.